Research Paper Volume 13, Issue 10 pp 13876—13897

Prognostic value of members of NFAT family for pan-cancer and a prediction model based on NFAT2 in bladder cancer

Validation of prognosis risk model. (A) Kaplan-Meier curves for OS time of patients with expression of NFAT2 in clinical study GSE100926. (B) Patients data from GSE100926 were divided by risk score into a high risk and a low risk groups. OS between two risk groups were analyzed and compared by Kaplan-Meier analysis. (C) 1-3-5 years ROC curves in GSE100926. The abscissa represents sensitivity, and the ordinate represents specificity. (D–F) The calibration curve for predicting 1-3-5 years OS for patients with BLCA. The Y-axis represents actual survival, as measured by K-M analysis, and the X-axis represents the nomogram-predicted survival (PG) The expression profiles of the NFAT2 in the normal bladder tissue and bladder specimens. Images were taken from the HPA.

Figure 12. Validation of prognosis risk model. (A) Kaplan-Meier curves for OS time of patients with expression of NFAT2 in clinical study GSE100926. (B) Patients data from GSE100926 were divided by risk score into a high risk and a low risk groups. OS between two risk groups were analyzed and compared by Kaplan-Meier analysis. (C) 1-3-5 years ROC curves in GSE100926. The abscissa represents sensitivity, and the ordinate represents specificity. (DF) The calibration curve for predicting 1-3-5 years OS for patients with BLCA. The Y-axis represents actual survival, as measured by K-M analysis, and the X-axis represents the nomogram-predicted survival (P<0.05). (G) The expression profiles of the NFAT2 in the normal bladder tissue and bladder specimens. Images were taken from the HPA.